Valneva SE (VALN) Research & Development (2021 - 2026)
Valneva SE's Research & Development was -$17.46 million in Q2 2026, compared with -$19.8 million a year earlier.
Powered by 
Analysis
Valneva SE (VALN) Research & Development (2021 - 2026) Analysis & Trends
On a trailing twelve-month basis, Valneva SE's Research & Development was -$96.94 million through Jun 30, 2026; for FY2025, it was -$96.38 million.
- In earlier years, Research & Development was -$79.23 million in FY2024, -$64.44 million in FY2023, -$107.05 million in FY2022 and -$205.06 million in FY2021.
- The Q2 2026 figure marks the highest quarterly Research & Development since Q1 2025.
- Per Business Quant data, VALN's Research & Development in the three quarters before Q2 2026 was -$17.81 million (Q1 2026), -$29.77 million (Q4 2025) and -$31.9 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Valneva SE | 561.40 Mn | 1.51 Mn | 1.86 Mn | -17.46 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -17.46 Mn |
| Mar 31, 2026 | -17.81 Mn |
| Dec 31, 2025 | -29.77 Mn |
| Sep 30, 2025 | -31.90 Mn |
| Jun 30, 2025 | -19.80 Mn |
| Mar 31, 2025 | -15.73 Mn |
| Dec 31, 2024 | -27.33 Mn |
| Sep 30, 2024 | -20.74 Mn |
| Jun 30, 2024 | -17.82 Mn |
| Mar 31, 2024 | -14.27 Mn |
| Dec 31, 2023 | -19.02 Mn |
| Sep 30, 2023 | -17.68 Mn |
| Jun 30, 2023 | -12.97 Mn |
| Mar 31, 2023 | -15.10 Mn |
| Dec 31, 2022 | -30.14 Mn |
| Sep 30, 2022 | -23.70 Mn |
| Jun 30, 2022 | -33.29 Mn |
| Mar 31, 2022 | -23.22 Mn |
| Dec 31, 2021 | -64.12 Mn |
| Sep 30, 2021 | -45.40 Mn |
API Access
Valneva SE Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=VALN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "VALN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=VALN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();